chemical · input

Polyglycolic acid (PGA) and polyester polymer for absorbable sutures

PGA/PLGA polymers extruded into absorbable suture monofilament; degrade via hydrolysis in tissue; key intermediate for Ethicon (J&J) Vicryl® and Covidien Polysorb; few qualified polymer suppliers globally

4

Source countries

6

Companies

1

Goods affected

0

Claims on record

What depends on it

Goods that need this input

1 essential American goods rely on polyglycolic acid (pga) and polyester polymer for absorbable sutures somewhere upstream in their supply chain.

Where it comes from

Source countries

Share of global supply, by country.

CountryShare of supply
NLNetherlands40%
DEGermany30%
USUnited States15%
JPJapan8%

Who makes it

Supplier companies

6 companies produce polyglycolic acid (pga) and polyester polymer for absorbable sutures.

Medtronic plc(MDT)

HQ IE3% share

Medical-device giant; absorbed Covidien — maker of Polysorb braided absorbable sutures and surgical products.

Corbion N.V.

HQ NL

Dutch biobased ingredient company (Euronext Amsterdam: CRBN, HQ Amsterdam; formerly CSM N.V. sugar/food division); world's largest producer of lactic acid and pharmaceutical-grade lactates via bacterial fermentation of corn starch and sugar. Corbion's Purac® pharmaceutical sodium lactate (formerly Purac Biochem, now Corbion Pharmaceutical Ingredients) meets USP/EP requirements for injectable sodium lactate used in Lactated Ringer's solution. Corbion is simultaneously the leading pharma sodium lactate supplier, the leading polylactic acid (PLA) bioplastic monomer supplier (LUMINY® PLA for packaging, 3D printing, medical devices), and a major food ingredient company (lactic acid as preservative E270, emulsifiers for baked goods). One Dutch company is the foundational supplier for: hospital Ringer's IV bags, compostable coffee cups, biodegradable 3D printing filament, and artisan bread shelf life extension — all from the same bacterial fermentation process using corn starch as feedstock. Corbion operates fermentation plants in the Netherlands (Gorinchem), Thailand (lactic acid capacity), and USA (Blair NE).

Ethicon (Johnson & Johnson MedTech)

HQ US

J&J's surgical products subsidiary; world's largest manufacturer of sutures, wound closure, and surgical stapling devices; Vicryl® absorbable suture controls the largest share of the global suture market; also makes electrosurgical devices and surgical mesh.

Evonik Industries AG(EVK)

HQ DE

Evonik Industries AG (XETRA: EVK; Essen Germany; MDAX listed); world's largest DL-methionine producer under the MetAMINO brand. Total DL-methionine capacity exceeds 700,000 MT/year across three continental hubs: Jurong Island Singapore (~340,000 MT/year — world's largest single methionine complex, expanded +40k MT August 2024), Theodore Mobile County Alabama USA (~245,000 MT/year), and Antwerp Belgium (~120,000 MT/year). The Wesseling Germany DL-Met line closed Q1 2021 as Evonik consolidated production to the three-hub network. Evonik first commercialized DL-methionine synthesis in the 1950s under predecessor Degussa. MetAMINO is Evonik's largest single product. ~30-32% global market share. In February 2022 Evonik announced a $176.5M investment in a new methyl mercaptan (MMP intermediate feedstock) plant at the Alabama site.

Kureha Corporation

HQ JP

Japanese specialty chemicals; produces bead-shaped activated carbon (BAC) for high-performance water treatment; Iwaki Japan facility

Mitsui Chemicals(4183.T)

HQ JP

Japanese chemical conglomerate (TYO: 4183, HQ Tokyo); recognized as the quality leader for ultra-high-purity electronic grade IPA for semiconductor applications, achieving parts-per-billion impurity levels. In Q2 2024, Mitsui Chemicals introduced a bio-based IPA derived from renewable acetone with 25,000 MT/year initial capacity — part of Japan's push toward bio-based chemicals. Mitsui is one of the world's leading specialty chemical companies with deep ties to the Mitsui Group keiretsu (same group as Mitsui & Co. trading, Mitsui Fudosan real estate, etc.). Mitsui Chemicals' IPA is particularly important for Japanese and Taiwanese semiconductor fabs. The company that dominates bio-based IPA is also part of the same industrial group that owns one of Japan's largest steel mills (Nippon Steel was historically Mitsui-linked).